Ypsomed Holding AG

YPSN

Company Profile

  • Business description

    Ypsomed, based in Burgdorf, Switzerland, develops and manufactures self-injection devices like pens, autoinjectors, and infusion systems for global pharma and biotech companies. The company shifted focus to business-to-business injection systems, divesting its diabetes care segment to supply device platforms to pharma partners.The company operates in a market driven by strong growth in biologics, biosimilars, patient self-administration, and GLP-1 therapies for obesity. To meet demand, Ypsomed has embarked on an ambitious capacity expansion program, with capital expenditure reaching approximately 50% of sales in recent years. This investment is partially derisked through customer co-financing, which aligns incentives and secures future volume commitments before launch.

  • Contact

    Brunnmattstrasse 6
    Burgdorf3401
    CHE

    T: +41 344244111

    E: [email protected]

    https://www.ypsomed.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 March 2027

    Employees

    2,099

Stocks News & Analysis

stocks

5 star fully franked ASX dividend payer

Investors in cheap ASX share with a narrow moat enjoys a high yield, but there are risks investors should be aware of.
stocks

An undervalued stock to buy that even Warren Buffett likes

Trading at an 18% discount, this wide-moat stock is a rare find.
stocks

ASX REIT downgraded following underwhelming exit

Discounted exit raises investor concerns.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,886.6035.900.41%
CAC 408,072.426.06-0.08%
DAX 4025,517.46143.040.56%
Dow JONES (US)51,481.51347.11-0.67%
FTSE 10010,680.204.68-0.04%
HKSE24,523.57118.94-0.48%
NASDAQ26,820.38248.34-0.92%
Nikkei 22565,481.27396.35-0.60%
NZX 50 Index13,683.63147.05-1.06%
S&P 5007,683.690.000.00%
S&P/ASX 2008,709.3029.600.34%
SSE Composite Index3,830.456.830.18%

Market Movers